Lactobacillus paracasei WIS43 alleviates DSS-induced colitis by modulating gut microbiota and suppressing inflammation
Key Points
Alleviating inflammation in ulcerative colitis suggests Lactobacillus paracasei WIS43 could be effective in treatment.
The probiotic candidate WIS43 potentially improves gut microbiota balance and immune response.
Analysis evaluated the impact of WIS43 on gut health by observing changes in microbiota and inflammation.
This highlights the importance of Lactobacillus paracasei WIS43 in developing probiotics for inflammatory bowel disease.
Abstract
These findings identify WIS43 as a promising probiotic candidate for the prevention and treatment of UC, supporting its therapeutic potential through coordinated modulation of host immunity and gut microbiota.